3 - 3 |
Communicating science Seija BC |
5 - 5 |
Density functional theory heads the wrong way Jacoby M |
6 - 6 |
Probing different types of Alzheimer's Arnaud C |
6 - 6 |
Phosphorus garners an organic starring role Ritter S |
7 - 7 |
Study confirms'hydrogen spillover' Borman S |
7 - 7 |
Possible molecular mechanism behind gastric bypass success identified Cross R |
8 - 8 |
Blood clot prevention with lower bleeding risk Torrice M |
8 - 8 |
Actinide covalency measured by EPR Kemsley J |
8 - 8 |
Superstretchy semiconducting polymers Davenport M |
9 - 9 |
Tetratriflylpropene: A new organic superacid Ritter S |
9 - 9 |
How HIV inserts DNA into hosts Everts S |
9 - 9 |
Biocatalytic cofactor recycled efficiently Borman S |
10 - 10 |
New drug approvals plummet in 2016 Mullin R |
10 - 10 |
As Chinese industry booms, residents choke Tremblay JF |
11 - 11 |
DOE funds cleantech, but will it last? Bomgardner M |
11 - 11 |
Drug manufacturing woes grow Thayer A |
12 - 12 |
Covestro funds catalyst R&D center Scott A |
12 - 12 |
Synthego raises funds from big names Thayer A |
12 - 12 |
Sumitomo, Purdue target plant analysis Bomgardner M |
12 - 12 |
Air Liquide exits diving equipment Reisch M |
12 - 12 |
DuPont settles mercury suit Reisch M |
12 - 12 |
Petrobras sells business at a bargain price Tullo A |
12 - 12 |
Air Products, Huntsman complete sales Tullo A |
12 - 13 |
Lonza to make drug active for Aurinia Mccoy M |
13 - 13 |
Life science fund gets interdisciplinary Mullin R |
13 - 13 |
Lilly, Bayer help animal health deal Thayer A |
13 - 13 |
A flurry of deals signed by J&J Mccoy M |
13 - 13 |
Chinese firm hampers FDA inspection Tremblay JF |
15 - 15 |
Chemical risk assessment headed in new direction Erickson B |
15 - 15 |
EPA finds risks with flea collar chemical Erickson B |
15 - 15 |
Texas sues FDA over execution drug Hess G |
15 - 15 |
EU queues up substances for possible restrictions Hogue C |
16 - 17 |
The great lint migration Bomgardner MM |
18 - 19 |
Evonik Industries is C&EN's company of the year Tullo AH |
20 - 21 |
C&EN talks with Rommie Amaro, computational chemist Bourzac K |
22 - 23 |
BASF's outlook for Asia brightens Tremblay JF |
24 - 25 |
NOBCChE cultivates young scientists Huber J |
25 - 25 |
NOBCChE goes to court [Anonymous] |
27 - 27 |
Despite new capacity, 2017 will likely be a strong year Tullo A |
27 - 27 |
A new year begins, marked by optimism Bomgardner M |
28 - 28 |
Sustainability to offer growth opportunities in anemic market Scott A |
28 - 28 |
Changing landscape ahead for crop solutions Bomgardner M |
29 - 29 |
China is slowing down, but regional growth is solid Tremblay JF |
29 - 29 |
Immuno-oncology therapies set to take center stage Thayer A |
30 - 30 |
New spending may knock country out of a rut Tullo A |
30 - 30 |
Paris Agreement, consumers to drive demand for biobased chemicals Bomgardner M |
31 - 31 |
Stars will align in semiconductors and displays Tremblay JF |
31 - 31 |
Pharmaceutical chemicals expected to glide through political, pipeline waves Mullin R |
32 - 32 |
A struggling region looks for recovery Tullo A |
32 - 32 |
Sector is expected to regain momentum this year Reisch M |
33 - 33 |
Buoyant outlook seen, as downstream diversification continues Scott A |
33 - 33 |
Pharma and diagnostics offer continued growth Thayer A |
34 - 34 |
Predicting science policy under the new Administration Nelson D |
40 - 40 |
Happy rats have pinker ears Kemsley J |